GOLDMAN SACHS GROUP INC - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 91 filers reported holding SYNTA PHARMACEUTICALS CORP in Q1 2015. The put-call ratio across all filers is 2.10 and the average weighting 0.9%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2016$69,000
+155.6%
264,978
+133.3%
0.00%
Q1 2016$27,000
-94.1%
113,570
-91.3%
0.00%
Q4 2015$459,000
-46.9%
1,304,762
+162.6%
0.00%
Q3 2015$865,000
+19.8%
496,843
+53.5%
0.00%
Q2 2015$722,000
-4.2%
323,752
-16.8%
0.00%
Q1 2015$754,000
-29.5%
388,901
-3.6%
0.00%
Q4 2014$1,069,000
-55.1%
403,400
-49.0%
0.00%
-100.0%
Q3 2014$2,379,000
-23.6%
790,232
+3.9%
0.00%0.0%
Q2 2014$3,112,000
-1.3%
760,931
+4.0%
0.00%0.0%
Q1 2014$3,152,000
+330.6%
731,321
+423.2%
0.00%
Q4 2013$732,000
+271.6%
139,771
+348.0%
0.00%
Q3 2013$197,000
-88.8%
31,202
-91.2%
0.00%
-100.0%
Q2 2013$1,763,000
+5.9%
353,389
+91.5%
0.00%0.0%
Q4 2012$1,664,000
+1286.7%
184,520
+1069.5%
0.00%
Q3 2012$120,000
-18.4%
15,778
-41.1%
0.00%
Q2 2012$147,000
-0.7%
26,799
-20.3%
0.00%
Q1 2012$148,00033,6280.00%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q1 2015
NameSharesValueWeighting ↓
CAXTON CORP 37,058,136$71,893,00085.78%
ARMISTICE CAPITAL, LLC 3,240,000$6,286,0002.79%
IRONWOOD INVESTMENT MANAGEMENT LLC 738,748$1,433,0000.26%
Geller Advisors LLC 187,323$363,0000.21%
Verity Asset Management, Inc. 56,518$110,0000.11%
STONERIDGE INVESTMENT PARTNERS LLC 334,713$649,0000.08%
Cutler Capital Management, LLC 72,500$140,0000.06%
BLUE ARROW CAPITAL MANAGEMENT LLC 199,930$388,0000.04%
Jefferies Group LLC 3,240,000$6,286,0000.04%
SABBY MANAGEMENT, LLC 399,000$794,0000.03%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders